Quantcast
Close Window
   
Welcome :o)
If healthcare, consumer and food products were safe, we wouldn't need a healthcare industry ;o)
 
or the FDA, CDC, ACA, NIH, etc...
 
Now THAT sure would save a shit-load of money, wouldn't it ;o)
HomeAbout

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

Hi All,
This is INDEPENDENT, AD-FREE work that you are certainly NOT going to see in conventional media.
 
Thanks to all who help keep JohnsonAndToxin ad-free, online and me working to expose Johnson & Johnson and their 275+ subsidiaries for the benefit of every man, woman and child on the planet - and that INCLUDES YOU and the ones YOU love.
 
Thank you,   
Emily
 
$.00         
Glad to see you :o)
Hi All,
This is INDEPENDENT work that you are certainly NOT going to see in conventional media.
Gifts of support are always very much appreciated...
 
Thank you,
Emily
 
$.00         

Notable visitors to the web site include:
 
US GOVERNMENT:
United States Air Force
US Senate
US Department of Defense
US Department of Justice
US Homeland Security
US Centers for Disease Control
 
GLOBAL FINANCIAL INSTITUTIONS:
Vanguard
Barclays
The Bank of New York Mellon Corp
Lloyds Banking Group PLC
Royal Bank of Canada
Bank of America
Harris Trust & Savings Bank
Deutsche Bank
Macquarie Bank
PNC Bank
Crédit Agricole Bank
Royal Bank of Scotland
Raymond James Financial
BlackRock Financial Management
...and many, many more from all over the world ;o)
 
Feel free to browse list of notable visitors to the web site.
 
Sponsored in part by...
Risperdal Boys Project Undisclosed to patients, Risperdal causes breast growth in boys.
----- / / -----
Examining Medicine An in-depth comprehensive, frequently updated look at extreme risks and permanent brain damage caused by psychiatric drugs.
----- / / -----
Fiddaman Blog Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
----- / / -----
Special Needs Advocate Power Join me as we work hard to ensure what our very special children need.

Johnson & Johnson Global Lawsuit Update: 48,500 and Skyrocketing
Take a look at the cost of more than 48 thousand US lawsuits pending against Johnson & Johnson.

Keywords: levaquin, risperdal, asr, hip, transvaginal, tvt, mesh, lawsuit
Date Created/Edited: September 18, 2014
 

Most Recent Content....
Johnson & Johnson Adds Another Two Thousand Lawsuits in Third Quarter 2017 (2017, November 17)
Lawsuits against Johnson & Johnson continue to spiral out of control - breaking over 108,000 in third quarter 2017, with numerous unmentioned products also racking up an untold number of lawsuits not mentioned in 2017 10-Q.
talc, risperdal, asr, xarelto, baby powder, tvt, mesh, lawsuit
 
History of Johnson & Johnson Janssen Fentanyl
Hmm, looks like Johnson & Johnson is profiting from BOTH sides of opioid addiction crisis ;o)
 
15 Steps to Solve Healthcare Crisis
How about this for a rough outline of a strategy to dramatically reduce healthcare costs?
 
ACA the Affordable CORRUPTION Act
The only purpose of the ACA/ObamaCare was to force everyone to pay legal fees and victim settlements and care from harm by Johnson & Johnson.
 
Johnson & Johnson Begs US FDA to Expand Xarelto Slaughter
After killing around 2,000 people in the United States in 2016 alone, Johnson & Johnson wants to spread the deaths even more!
 
Johnson & Johnson Facing Over $100 BILLION in Lawsuit Debt
With a flood of lawsuits pouring in from around the world, Johnson & Johnson is facing at least $100 BILLION lawsuit debt.
 
The Johnson & Johnson Drugged Kids Pension Plan
Teacher and state retirement funds invest in Johnson & Johnson, the DRUGGED KIDS PENSION PLAN
 
Second Quarter 2017 Lawsuits Against Johnson & Johnson
Lawsuits against Johnson & Johnson in United States holding at 106,600! DOES NOT INCLUDE ALL PRODUCTS FACING LAWSUITS OR LAWUITS FILED OUTSIDE THE UNITED STATES!
 
Special Sections....
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

 
Recent Content....
Why President Trump Should Shut Down US FDA (2017, March 28)
Healthcare organizations around the world depend on US FDA decisions, however, profit, rather than safety, seems to be the primary motivation.
healthcare, health, obamacare, donald, trump, fda, fraud, kickback
 
The Difference Between Guinea Pig and Cash Cow (2016, September 27)
People keep saying pharma is using us as 'guinea pigs'. Uh, not quite. Take a minute to learn the difference between a 'guinea pig' and a 'cash cow'.
guinea pig, immunization, vaccination, profit, harm, autism, disability, asthma
 
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
 
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
 
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
 
When I found out that I can find out how many victims of Johnson & Johnson known defective drugs and devices have filed lawsuits from their Annual Shareholder Report, I decided to investigate the 2013 Annual Shareholder Report for the numbers of victims of so many horrible products. It wasn't exactly easy to find, but in Section 21, Legal Proceedings on page 64, the Product Liability section the products and the number of victims that have filed lawsuits really are listed. So, let's take a closer look at this - and the potential costs. After running the numbers, it's quite obvious that there is a good possibility that the incredible number of lawsuits will soon sink the company.
 
The 2013 Shareholder Report Discloses:
1,165 Levaquin Lawsuits
12,340 ASR Hip Lawsuits
5,560 Pinnacle Hip Lawsuits
500 Risperdal Lawsuits
28,810 Mesh Product Lawsuits
22 Duragesic Lawsuits
140 Topomax Lawsuits
 
While this lawsuit list looks pretty short compared to what I've been seeing regarding Xarelto, Heart Stents, butt staplers, bone cement and other product lawsuits, for the sake of this article, we'll just stick to what J&J admits in their shareholder report, and see what's on for next year. In addition, keep in mind that this is only a list for the United States. Lawsuits filed in Australia, Belgium, Canada, England, Israel, Italy, the Netherlands, Scotland, the United Kingdom and Venezuela are not included - but will have a huge impact on the total going out in liability costs and compensation, as well as the global reputation of the company.
 
So, going with only the lawsuits listed in the shareholder report, and only the lawsuits filed in the United States, it appears that there are over 48,537 lawsuits pending as of the 2013 Shareholder Annual Report. As stated in the report, 8,000 of these were covered by the Class Action suit which is in appeal, for $2.5 billion. So, dumping those victims, there are still over 40,000 lawsuits pending in the US.
 

With just a little bit of math, basically move a bunch of zero's, it's pretty simple to see that, if each of these costs only a bare minimum of $1,000,000 to fight, lose and then appeal, the cost will be over $40,000,000,000. If only half settle for a bare minimum of $1,000,000 - the total comes to over $60 billion - a major cut into J&J's net worth of $78 billion. This will leave only $18 billion to deal with the lawsuits filed from the other 10 countries mentioned in the Shareholder Report.
 
I compared the number of product liability lawsuits from the 2013 Shareholder Report to the number of lawsuits from the 2012 Shareholder Report. Amazingly, the number of lawsuits more than DOUBLED! Product liability lawsuits went from 20,680 in 2012 to 48,537. Um, MORE THAN DOUBLED!
 
I don't know about you - but it looks like lawsuits finally outweigh income and assets. It seems that J&J is headed for bankruptcy. Obviously, trying to prevent that, J&J recently sold off KY, Ortho Diagnostics and is trying to sell off Cordis. However, selling Cordis will likely be very challenging, considering the litigation not mentioned in the Shareholder Report for defective Cypher Heart Stents.
 
Further in Section 21 lawsuits for other subjects are included as well. I'm only concerned about the victims of known harmful and defective products - which, is obviously enough to drain the equity right out of J&J - globally.
 
It's not much of a wonder now why Berkshire and Trojan dumped JNJ stock - and insiders are selling it off as quickly as quietly possible. This company isn't worth shit, and their products obviously suck.
 
Resources:
1. Johnson & Johnson (2013, December). Johnson & Johnson 2013 Shareholder Report. Johnson & Johnson. Retrieved from http://files.shareholder.com/downloads/JNJ/3461521603x0x733042/DDD2ABD5-2CC6-41D2-8ACB-EC2A967727E4/ar2013_JNJ.pdf
 
2. Yahoo (2014, June). Johnson & Johnson Balance Sheet (Quarterly). YCharts (Yahoo Finance). Retrieved from http://ycharts.com/financials/JNJ/balance_sheet/quarterly
 
3. Johnson & Johnson (2012, December). Johnson & Johnson 2012 Shareholder Report. Johnson & Johnson. Retrieved from http://files.shareholder.com/downloads/JNJ/3461521603x0x644760/85FD0CFF-2305-4A02-8294-2E47D0F31850/JNJ2012annualreport.pdf
 
All contents Copyright © 2012-2017 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
 
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
 
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
 
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries